$1.50
3.23% today
Nasdaq, Sep 23, 06:08 pm CET
ISIN
US81362J1007
Symbol
VANI

Second Sight Medical Products, Inc. Stock price

$1.55
+0.31 25.00% 1M
+0.46 42.20% 6M
+0.39 33.62% YTD
+0.34 28.10% 1Y
-1.02 39.69% 3Y
-0.97 38.49% 5Y
-224.05 99.31% 10Y
-477.73 99.68% 20Y
Nasdaq, Closing price Mon, Sep 22 2025
+0.14 9.93%

Key metrics

Basic
Market capitalization
$91.8m
Enterprise Value
$85.0m
Net debt
positive
Cash
$6.8m
Shares outstanding
59.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
18.7
Financial Health
Equity Ratio
42.4%
Return on Equity
-130.6%
ROCE
-120.7%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-26.4m | -
EBIT
$-26.8m | $-27.7m
Net Income
$-25.5m | $-23.9m
Free Cash Flow
$-23.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-5.9% | -
EBIT
-6.0% | -10.9%
Net Income
-5.5% | -3.8%
Free Cash Flow
-7.5%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.4
FCF per Share
$-0.4
Short interest
0.7%
Employees
37
Rev per Employee
$0.0
Show more

Is Second Sight Medical Products, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

Second Sight Medical Products, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Second Sight Medical Products, Inc. forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Second Sight Medical Products, Inc. forecast:

Buy
88%
Hold
13%

Financial data from Second Sight Medical Products, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 9.31 9.31
5% 5%
-
- Research and Development Expense 17 17
7% 7%
-
-26 -26
6% 6%
-
- Depreciation and Amortization 0.40 0.40
8% 8%
-
EBIT (Operating Income) EBIT -27 -27
6% 6%
-
Net Profit -26 -26
5% 5%
-

In millions USD.

Don't miss a Thing! We will send you all news about Second Sight Medical Products, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Second Sight Medical Products, Inc. Stock News

Neutral
GlobeNewsWire
6 days ago
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology. It is the only company to have obtained FDA approval of a device providing artificial vision for the profoundly blind
Neutral
GlobeNewsWire
19 days ago
NPM-139 has potential to provide Wegovy®-level efficacy with once or twice-yearly administration First-in-human Phase 1 study is expected to initiate in the first half of 2026, pending regulatory clearance Preparations for dose-ranging Phase 2 study of NPM-139 to occur in parallel with Phase 1 study ALAMEDA, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) --  Vivani Medical, Inc. (Nasdaq: VANI) (“Vivan...
Neutral
GlobeNewsWire
about one month ago
ALAMEDA, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. ( NASDAQ: VANI ) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, announced today that CEO Adam Mendelsohn, Ph.D., will present a company overview and conduct partnering meetings at the H.C. Wainwright 27th Annual Global Investment Conference, tak...
More Second Sight Medical Products, Inc. News

Company Profile

Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. It operates through the following geographical segments: United States, Italy, France, and China. The firm's product include Argus II Retinal Prosthesis System that treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP. The company was founded by Alfred E. Mann, Aaron Mendelsohn, Sam Williams, Robert J. Greenberg, and Gunnar Bjorg in 1998 and is headquartered in Sylmar, CA.

Head office United States
CEO Adam Mendelsohn
Employees 37
Founded 2003
Website vivani.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today